Negative capsule endoscopy without subsequent enteroscopy does not predict lower long-term rebleeding rates in patients with obscure GI bleeding.

Park, Jae Jun; Cheon, Jae Hee; Kim, Hee Man; Park, Hyeun Sung; Moon, Chang Mo; Lee, Jin Ha; Hong, Sung Pil; Kim, Tae Il; Kim, Won Ho
Gastrointestinal endoscopy
2010May ; 71 ( 6 ) :990-7.
저자 상세정보
Park, Jae Jun -
Cheon, Jae Hee -
Kim, Hee Man -
Park, Hyeun Sung -
Moon, Chang Mo -
Lee, Jin Ha -
Hong, Sung Pil -
Kim, Tae Il -
Kim, Won Ho -
ABSTRACT
BACKGROUND: Capsule endoscopy (CE) is now widely accepted as a first-line diagnostic modality for obscure GI bleeding (OGIB). However, the clinical implications of negative results of CE studies remain unclear. OBJECTIVE: To investigate long-term (>1 year) outcomes for patients undergoing CE for OGIB and to identify risk factors associated with rebleeding. DESIGN AND SETTING: Retrospective study in a tertiary care hospital.

METHODS: A total of 57 consecutive patients who had undergone CE for OGIB were enrolled and their pre- and post-CE clinical data were collected. Specific treatments were defined as treatments directly aimed at presumed bleeding causes including hemostasis and disease-specific medical therapy, whereas nonspecific treatments were defined as symptomatic treatments for anemia.

RESULTS: Of the 57 patients, the indication for CE was obscure-overt bleeding in 46 patients and obscure-occult bleeding in 11 patients. Among 51 patients for whom long-term data were available, significant (P2) lesions were found in 23 (45.1%) patients. The overall rebleeding rate was 35.3% during a median follow-up duration of 31.7 months (range 12.8-58.0 months). There was no statistically significant difference in the cumulative rebleeding rate between patients with positive and negative CE results (34.8% vs 35.7%, respectively; P = .989). However, specific treatments after CE (hazard ratio, 0.111; 95% CI, 0.013-0.980; P = .043) significantly decreased rebleeding. LIMITATIONS: Small number of patients, retrospective study design.

CONCLUSIONS: The rebleeding rate for patients with OGIB and negative CE results was substantial, indicating that these patients should be closely observed. However, specific treatment after CE significantly reduced the incidence of recurrent bleeding. CI - 2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.
na
MESH
Adult, Aged, *Capsule Endoscopy, Endoscopy, Gastrointestinal, Female, Gastrointestinal Hemorrhage/*etiology, Humans, Male, Middle Aged, Predictive Value of Tests, Recurrence, Retrospective Studies, Risk Factors, Time Factors
링크

주제코드
주제명(Target field)
연구대상(Population)
연구참여(Sample size)
대상성별(Gender)
질병특성(Condition Category)
연구환경(Setting)
연구설계(Study Design)
연구기간(Period)
중재방법(Intervention Type)
중재명칭(Intervention Name)
키워드(Keyword)
유효성결과(Recomendation)
Specific treatments after CE (hazard ratio, 0.111; 95% CI, 0.013-0.980; P = .043) significantly decreased rebleeding.
연구비지원(Fund Source)
근거수준평가(Evidence Hierarchy)
출판년도(Year)
참여저자수(Authors)
대표저자
DOI
10.1016/j.gie.2009.12.009.
KCD코드
ICD 03
건강보험코드